|

Trastuzumab deruxtecan (DS-8201a) Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1

Indications

  • HER2/Neu-positive Breast Cancer1
  • Her2/Neu Positive Advanced Solid Tumors1
  • Trastuzumab1
  • Breast Cancer With Bone Metastasis1
  • Radiomic1

Other1 trial

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.